Evidence for mild blue-yellow colour vision deficits immediately following fluorescein angiography

2000 ◽  
Vol 20 (2) ◽  
pp. 137-141
Author(s):  
Marcel J. Sankeralli ◽  
John C. Chen ◽  
Andrew B. Metha ◽  
Kathy T. Mullen
BDJ ◽  
2016 ◽  
Vol 221 (5) ◽  
pp. 227-228 ◽  
Author(s):  
F. Mushtaq ◽  
R. C. Baraas ◽  
L. M. Al-Saud ◽  
I. Mirghani ◽  
C. van der Zee ◽  
...  

2019 ◽  
Vol 44 (1) ◽  
pp. 16-23 ◽  
Author(s):  
Neda Anssari ◽  
Reza Vosoughi ◽  
Kathy Mullen ◽  
Behzad Mansouri

1992 ◽  
Vol 15 ◽  
pp. 648B
Author(s):  
M. Dietzel ◽  
Th. Kapitany ◽  
E. C. Zach ◽  
O. Inan ◽  
R. Frey

Author(s):  
Alexandra C. Harrison ◽  
Werner J. Becker ◽  
William K. Stell

ABSTRACT:A battery of colour vision tests was employed to evaluate visual function in patients with multiple sclerosis (M.S.). Colour deficits were found in 45% of patients tested with the Ishihara plates and 42.5% of patients tested with the FM 100-Hue test. 65% of M.S. patients failed at least one of the tests.The colour vision deficits were not restricted to patients with optic neuritis or with visual evoked potential (VEP) abnormalities and there was no significant correlation between an abnormal VEP latency and a colour vision deficit. Colour vision testing may be a useful option to consider in the investigation of M.S. patients, even if there is no other evidence of visual system involvement.


2013 ◽  
Vol 16 (3) ◽  
pp. 535-547 ◽  
Author(s):  
Lea M. Hulka ◽  
Michael Wagner ◽  
Katrin H. Preller ◽  
Daniela Jenni ◽  
Boris B. Quednow

Abstract Specific blue–yellow colour vision impairment has been reported in dependent cocaine users and it was postulated that drug-induced changes in retinal dopamine neurotransmission are responsible. However, it is unclear whether these changes are confined to chronic cocaine users, whether they are specific for dopaminergic stimulants such as cocaine and amphetamine and whether they are related to cognitive functions such as working memory, encoding and consolidation. In 47 occasional and 29 dependent cocaine users, 23 MDMA (commonly known as ‘ecstasy’) users and 47 stimulant-naive controls, colour vision discrimination was measured with the Lanthony Desaturated Panel D-15 Test and memory performance with the Auditory Verbal Learning Test. Both occasional and dependent cocaine users showed higher colour confusion indices than controls. Users of the serotonergic stimulant MDMA (26%), occasional (30%) and dependent cocaine users (34%) exhibited more frequent blue–yellow colour vision disorders compared to controls (9%). Inferior performance of MDMA users was caused by a subgroup with high amphetamine co-use (55%), while MDMA use alone was not associated with decreased blue–yellow discrimination (0%). Cognitive performance was worse in cocaine users with colour vision disorder compared to users and controls with intact colour vision and both colour vision impairment and cognitive deficits were related to cocaine use. Occasional cocaine and amphetamine use might induce blue–yellow colour vision impairment, whereas the serotonergic stimulant MDMA does not impair colour vision. The association between colour vision impairment and cognitive deficits in cocaine users may reflect that retinal and cerebral dopamine alterations are linked to a certain degree.


1985 ◽  
Vol 191 (4) ◽  
pp. 223-226 ◽  
Author(s):  
B.C.P. Polak ◽  
M. Leys ◽  
G.H.M. van Lith

1998 ◽  
Vol 82 (5) ◽  
pp. 510-516 ◽  
Author(s):  
A Landers ◽  
I E Murdoch ◽  
J Birch ◽  
S N Cousens ◽  
O E Babalola ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document